Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-26

Clinical Trial Update: Indomethacin for Refractory Chronic Cough [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for indomethacin in refractory chronic cough is reported, with unknown status.</summary>

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Refractory Chronic Cough | Phase 3 | Status: UNKNOWN